Marcus Webb
Longevity Writer
Marcus covers aging biology and the longevity peptide conversation. He has followed the field since the early telomere debates and keeps a long memory for claims that did not survive replication.
FDA Approves Hovilpri for Resistant Herpes Lesions
FDA approved pritelivir, a new antiviral for immunocompromised patients with herpes lesions unresponsive to standard treatments.
VIP Peptide Research Overview: What Studies Show About Vasoactive Intestinal Peptide
A clear look at what VIP peptide research actually shows about inflammation, circadian rhythm, and gut and lung tissue.
Tirzepatide May Switch On Brown Fat in Mice
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, activates calorie burning brown fat beyond appetite suppression.
Compounded Glutathione Injectables Recalled Over Endotoxin Contamination
Centric Compounding recalled six lots of injectable Glutathione, Myer's Cocktail, and Tri Immune Boost after endotoxin contamination reports.
FDA Authorizes Nitenpyram to Prevent New World Screwworm in Pets
FDA expanded an emergency authorization so nitenpyram tablets can now prevent, not just treat, screwworm infestations in dogs and cats.
Epitalon: The Research Behind the Pineal Peptide
Epitalon is an investigational tetrapeptide studied for possible effects on telomerase and pineal aging, with no approval anywhere.
Longevity Peptides: What the Research Actually Shows
A measured look at epithalon, NAD plus, NMN, glutathione, humanin, SS-31, and FOXO4-DRI, and what longevity peptide research actually shows.